Neumora Therapeutics Inc.... (NMRA)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
1.94
-0.07 (-3.48%)
At close: Jan 29, 2025, 3:59 PM
1.93
-0.26%
After-hours Jan 29, 2025, 07:15 PM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
PE Ratio | -11.48 | -18.86 | -10.4 | -24.87 | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 5.77 | -5.53 | -7.59 | -26.16 | n/a |
P/FCF Ratio | -16.57 | -21.4 | -32.39 | -88 | n/a |
P/OCF Ratio | -16.59 | -21.49 | -32.74 | -92.27 | n/a |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | 0.01 | -0.02 | -0.01 | -0.02 | n/a |
Quick Ratio | 19.05 | 16.37 | 17.85 | 20.69 | n/a |
Current Ratio | 19.05 | 16.37 | 17.85 | 20.69 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a |
Return on Equity (ROE) | -0.5 | 0.29 | 0.73 | 1.05 | n/a |
Return on Assets (ROA) | -0.48 | -0.31 | -0.55 | -0.5 | n/a |
Return on Capital (ROIC) | -0.4 | -0.34 | -0.58 | -0.51 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a |